Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 25, 2024European Journal of Endocrinology

Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies

View Full Paper
Ask AI
Bookmark
Share

Authors

MBMaria Francesca BirtoloRPRebecca PedersiniAPAndrea Palermo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Birtolo et al. (2024) studied this question.

synapsesocial.com/papers/68e5f0a2b6db6435875852f8https://doi.org/10.1093/ejendo/lvae086
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Beyond Bone Mineral Density: Real-World Fracture Risk Profiles and Therapeutic Gaps in Postmenopausal Osteoporosis2025 · 1 citations
  2. 2Effectiveness and safety of bone protective interventions to mitigate bone loss and skeletal fractures experienced by patients with non-metastatic breast cancer: a systematic review and meta-analysis2026 · 2 citations
  3. 3Vertebral Fractures Beyond Bone Density in Breast Cancer: A Real-World Study of Endocrine Therapy and FRAX Reclassification2026
  4. 4Abstract PS1-03-18: Effects of cancer treatment on bone mineral density in premenopausal patients with early-stage breast cancer2026
  5. 5Breast cancer survivors are at an increased risk for osteoporotic fractures not explained by lower BMD: a retrospective analysis2015 · 13 citations